EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,119,294 | +47.3% | 308,841 | +44.6% | 0.10% | +94.1% |
| Q3 2022 | $2,118,000 | +1.3% | 213,599 | -0.0% | 0.05% | +6.2% |
| Q2 2022 | $2,091,000 | +0.2% | 213,600 | 0.0% | 0.05% | +2.1% |
| Q1 2022 | $2,086,000 | +7.5% | 213,600 | +6.8% | 0.05% | -7.8% |
| Q4 2021 | $1,940,000 | -0.3% | 200,000 | 0.0% | 0.05% | -10.5% |
| Q3 2021 | $1,946,000 | +0.2% | 200,000 | 0.0% | 0.06% | -6.6% |
| Q2 2021 | $1,942,000 | – | 200,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |